Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 7, 2001

View Archived Issues

Protherics Gains U.S. Approval Of CroFab, Raises £3.1M Privately

Growth Factor Discoveries Point To New Approach For Metastasis

Analytica Capitalizes On Taiwan Initiative Through New Subsidiary

Co.don Taking Cell Platform Public On Market In Germany

Bavarian Nordic Licenses Vaccine Technology From Australian Firm

Ethics Expert Describes EU Biotechnology 'Culture Shock'

GeneScan, Motorola Developing Device For On-Site DNA Analysis

SR Pharma, YM Biosciences Combine Products For Trial

Monitor Report Advises Israel To Take Initiatives In Biotech

Molecular Templates Taking Aim At Cancer Therapeutics

Novagali Sets Up Ginoptle Shop To Focus On Delivery Technology

Other News To Note

BioMérieux, Celera Collaborate On Improving Cancer Therapies

Parliament Committee Urges Caution In EU Biotech Industry

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...